Your browser doesn't support javascript.
loading
Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD.
Iqball, Sharifah; Beck, Daniel K; Devarajan, Gayathri; Khoo, Cheen P; O'Connor, Deirdre M; Ellis, Scott; Guzman, Efrain; Mitrophanous, Kyriacos A; Lad, Yatish.
Affiliation
  • Iqball S; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Beck DK; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Devarajan G; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Khoo CP; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • O'Connor DM; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Ellis S; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Guzman E; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Mitrophanous KA; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
  • Lad Y; Oxford Biomedica (UK) Ltd., Windrush Court, Transport Way, OX4 6LT Oxford, UK.
Mol Ther Methods Clin Dev ; 30: 350-366, 2023 Sep 14.
Article in En | MEDLINE | ID: mdl-37637380
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Mol Ther Methods Clin Dev Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Mol Ther Methods Clin Dev Year: 2023 Document type: Article Affiliation country: United kingdom Country of publication: United States